In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use

Journal of Antibiotics

Volumn 51, Issue 2, 1998, Pages 136-144

  Norcia, Laura J L ^a   Seibel, Scott B ^a   Kamicker, Barbara J ^a   Lemay, Mary A ^a   Lilley, Susan C ^a   Hecker, Scott J ^a   Bergeron, Jay M ^a   Retsema, James A ^a   Hayashi, Shigeru F ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CP 163 505; EDETIC ACID; ERYTHROMYCIN; MACROLIDE; MAGNESIUM ION; POLYMYXIN B NONAPEPTIDE; TILMICOSIN; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; ESCHERICHIA COLI; MANNHEIMIA HAEMOLYTICA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; PH; PRIORITY JOURNAL; VETERINARY MEDICINE;

ACTINOBACILLUS PLEUROPNEUMONIAE; ESCHERICHIA COLI; PASTEURELLA HAEMOLYTICA; PASTEURELLA MULTOCIDA;

EID: 0031908124     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.136     Document Type: Article

References (22)

1. WESLY, T.: The economics of animal disease. Animal Pharm, PJB Publications, Surrey, England. 1987
2. Elanco Animal Health, Micotil® label
3. MCFARLAND, J. M.; S. J. HECKER, B. J. JAYNES, M. R. JEFSON, K. M. LUNDY, C. B. VU, E. A. GLAZER, S. A. FROSHAUER, S. F. HAYASHI, B. J. KAMICKER, C. P. REESE & J. A. OLSON: Repromicin derivatives with potent antibacterial activity against Pasteurella multocida. Journal of Medicinal Chemistry 40: 1041-1045, 1997
4. JAYNES, B. H.; C. S. JONES, S. F. HAYASHI, M. LEMAY, C. P. REESE & S. B. SEIBEL: Macrolide modification by reductive amination: Antibacterial repromicin derivatives with functionalized alkylamine sidechains. The 20th IUPAC Symposium on the Chemistry of Natural Products. Abstract SY-36, Chicago, IL, 1996
5. LUNDY, K. M.; J. P. CRONIN, S. J. HECKER, M. L. MINICH, S. F. HAYASKU, B. J. KAMICKER, M. A. LEMAY, S. F. PETRAS, S. B. SEIBEL & P. C. CANNING: Synthesis and antibacterial activity of C-20 diamino-amides of repromicin. The 20th IUPAC Symposium on the Chemistry of Natural Products. Abstract SY-36, Chicago, IL, 1996
6. HAYASHI, S. F.; L. J. L. NORCIA, S. B. SEIBEL and A. M. SILVIA: Structure-activity relationship of hygromycin A and its analogs: protein synthesis inhibition activity in a cell free system. J. Antibiotics 50: 555-562, 1997
7. National Committee of Clinical Laboratory Standards: Methods for Determining Bactericidal Activity of Antimicrobial Agents, Doc. M26-T (Vol. 12, No. 19, 9/92) & Doc. M26-P (Vol. 7, No. 2, 1/87). Villanova, PA
8. LORIAN, V.: Antibiotics in Laboratory Medicine. Williams & Wilkins, Baltimore, MD, third edition., 1991
9. ISENBERG, H. D.: Clinical Microbiology Procedures Handbook. American Society of Microbiology Press, Washington DC, 1992
10. PANKUCH, G. A.; M. R. JACOBS & P. C. APPELBAUM: Study of comparative antipneumococcal activities of penicillin, RP 59500, erythromycin A, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrobial Agents and Chemotherapy 38: 2065-2072, 1994
11. CLANCY, J.; J. PETITPAS, F. DIB-HAJJ, W. YUAN, M. CRONAN, A. V. KAMATH, J. BERGERON & J. RETSEMA: Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Molecular Microbiology 22: 867-879, 1996
12. MAO, J. C.-H. & R. G. WIEGAND: Mode of action of macrolides. Biochimca et Biophysica acta 157: 404-413, 1968
13. OSE, E. E.: In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic. J. Antibiotics 40: 190-194, 1987
14. RETSEMA, J. A.; L. A. BRENNAN & A. E. GIRARD: Effects of environmental factors on the in vitro potency of azithromycin. European Journal of Microbiology and Infectious Disease 10: 834-842, 1991
15. LECLERCQ, R. & P. COURVALIN: Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35: 1267-1272, 1991
16. BARRY, A. L & P. C. FUCHS: Influence of the test medium on azithromycin and erythromycin A regression statistics. European Journal of Microbiology and Infectious Disease 10: 846-849, 1991
17. RETSEMA, J.; A. GIRARD, W. SCHELKLY, M. MANOUSOS, M. ANDERSON, G. BRIGHT, R. BOROVOY, L. BRENNAN & R. MASON: Spectrum and mode of action of azithromycin (CP-62,993). a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrobial Agents and Chemotherapy 31: 1939-1947, 1987
18. FARMER, S.; Z. LI & R. E. W. HANCOCK: Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. Journal of Antimicrobial Chemotherapy 29: 27-33, 1992
19. NIKAIDO, H. & M. VAARA: Molecular basis of bacterial outer membrane permeability. Microbiological Reviews 49: 1-32, 1985
20. NIKAIDO, H.: Outer membrane. Escherichia coli and Salmonella, second edition. Ed., F. C. NEIDHART, pp. 29-47, American Society for Microbiology, 1996
21. LEIVE, L.: The barrier function of the Gram-negative envelope. Annals of the New York Academy of Sciences 235: 109-127, 1974
22. CONRAD, R. S.; C. GALANOS & F. R. CHAMPLIN: Biochemical characterization of lipopolysaccharides extracted from a hydrophobic strain of Pasteurella multocida. Veterinary Research Communications 20: 195-204, 1996